LONDON, September 19, 2018 /PRNewswire/ --
The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.
(Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 241-page report you will receive 85 tables and 103 figures- all unavailable elsewhere.
The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
Cell-based Assays market forecasts from 2018-2028
Cell-Based Assays Market by Product Type: Instrument Consumables Software Services Reagents Assay Kits Microplates Cell Lines Probes & Labels
Cell-Based Assays Market by Application: Drug Discovery Basic Research Predictive Technology
Cell-based Assays Market by End-User: Pharma & Biotech Companies Academic Institutes CROs
This report provides individual revenue forecasts to 2028 for these national markets: US Japan Germany UK France Spain Italy China India Russia Brazil
Our study includes SWOT and STEP analysis of the cell-based assays market.
Our study discusses the selected leading companies that are the major players in the cell-based assays market: BD (Becton, Dickinson and Company) BioAgilytix Labs BioVision Cell Assay Innovations, Inc. Charles River Laboratories International CYTOO SA DiscoverX GE Healthcare InSphero Marin Biological Laboratories Molecular Devices Perkin Elmer Pharmaceutical Product Development Porsolt Promega ProQinase GmbH QGel SGS Group, Inc. Thermo Fisher Scientific (and Affymetrix acquisition)
This report also discusses technology, trends and future outlook of the cell-based assays industry
Visiongain's study is intended for anyone requiring commercial analyses for the cell-based assays market. You find data, trends and predictions.
Buy our report today Cell-Based Assays World Industry and Market 2018-2028: Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs.
To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/cell-based-assays-world-industry-and-market-2018-2028/
Abcam Accuri Cytometers, Inc. Affymetrix, Inc. Agilent Technologies Applied Biosystems Ascendance Biotechnology AstraZeneca ATCC AXAM Axiogenesis AG B'SYS GmbH BASF Bayer Becton, Dickinson and Company Becton Dickinson Asia Limited Becton Dickinson Biosciences BioAgilytix Labs BioCity Biocroi Biofungitek BioIVT Biotechnology Industry Research Assistance Council (BIRAC) BioVision, Inc. BMG LABTECH GmbH C.R. Bard Caliper Life Sciences, Inc. Cambridge Research & Instrumentation, Inc. Cell Assay Innovations (CAI) Cell Biolabs Charles River Germany GmbH & Co. KG Charles River Holdings LLC Charles River Laboratories Charles River Laboratories International, Inc. Charles River Laboratories, Inc. Charles River Nederland BV Charles River UK Limited Cisbio Bioassays Cohesive Technologies Inc. Contextual Genomics CYTOO SA Daiichi Sankyo Company Limited Danaher Corporation Department of Biotechnology (DBT) DiscoverX Dr. Reddy's Laboratories Draconis Pharma Eurofins Scientific S.E. EUROIMMUN US Inc. Food and Drug Administration (FDA) Fisher Scientific FLUOFARMA Foundation Top Institute Pharma Fulcrum Therapeutics GE Healthcare GE Healthcare AS GE Healthcare Bio-Sciences AB GE Healthcare BVBA GE Healthcare European Holdings SARL GE Healthcare Japan Corporation GE Healthcare USA Holding LLC General Electric Company GIMDx, Inc. Guangzhou Improve Medical Instruments HD Biosciences Co., Ltd. Helsinki Institute of Life Science Icagen, Inc. Idengene SA IncellDx, Inc Indian Institute of Chemical Technology (IICT) Innoprot InSphero AG IntelliCyt Interchim Invitrogen Janssen Jubilant Biosys Labcyte Inc. Lead Discovery Centre GmbH Likarda Luxcel Biosciences Ltd Marin Biologic Laboratories Mayflower Biosciences Merck KGaA Metrion Biosciences Ltd Molecular Devices, LLC NanoString Technologies, Inc. Ncardia NEOMED Institute Netherlands Cancer Institute Neuron BioServices NovaScreen Biosciences Corporation NovaWave Technologies, Inc. On Target Co., Ltd Oncotest Pelago Bioscience Perkin Elmer Inc. Phadia GmbH Pharmaceutical Product Development (PPD) Pharmaceutical Product Development, LLC. Phenomics Discovery Initiative (PDi) Pluriomics B.V. Porsolt Porsolt and Fluofarma acquisition Premas Lifescience Promega Corporation ProQinase GmbH QGel SA. Riken Genesis Russian Federation Sanofi Science Exchange SGS Australia SGS Belgium NV SGS Central America S.A. SGS Group SGS North America Inc. Skolkovo Foundation StemTek therapeutics Sygnature Discovery Syncom Sysmex Corporation Systems and Reagents Inc. Takeda Pharmaceutical Company Limited Tecan Group Ltd. The Structural Genomics Consortium Thermo Electron A/S Thermo Fisher Scientific (and Affymetrix acquisition) Thermo Fisher Scientific Operating Company LLC Thermo Fisher Scientific Senior Financing LLC Thermo Scientific Tufts Center for the Study of Drug Development UCB Unity Lab Services Valneva SE VitoTag Biosciences Xenogen Corporation ZF BioLabs ZF Biotox List of Organisations mentioned in the report All India Institute of Medical Sciences (AIIMS) American Society of Cell Biology (ASCB) AMR Centre (AMRC) Association of Research-Based Pharmaceutical Companies Biotechnology Industry Research Assistance Council (BIRAC) Department of Biotechnology (DBT) Foundation Top Institute Pharma Helsinki Institute of Life Science Imperial College London Indian Institute of Chemical Technology (IICT) Innovative Medicines Initiative (IMI) nstitute for Chemical Sciences in Rennes Institute for In Vitro Sciences, Inc. (IIVS) Institute for Molecular Medicine Finland (FIMM) Karolinska Institutet Medical Research Council (MRC) Centre for Regenerative Medicine (CRM) Memorial Sloan Kettering Cancer Center (MSK) National Health Service (NHS) National Phenotypic Screening Centre (NPSC) NEOMED Institute Netherlands Cancer Institute Oxford University Pharmaceutical Research and Manufacturers of America (PhRMA) Phenomics Discovery Initiative (PDi) Russian Federation Science Exchange Skolkovo Foundation Tufts Center for the Study of Drug Development Unity Lab Services University of Dundee University of Edinburgh University of Helsinki University of Oxford World Health Organization (WHO)
To see a report overview please e-mail Sara Peerun on [email protected]
SOURCE Visiongain
Advertisement
Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs
Advertisement
The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.
(Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 241-page report you will receive 85 tables and 103 figures- all unavailable elsewhere.
The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
Cell-based Assays market forecasts from 2018-2028
Cell-Based Assays Market by Product Type: Instrument Consumables Software Services Reagents Assay Kits Microplates Cell Lines Probes & Labels
Cell-Based Assays Market by Application: Drug Discovery Basic Research Predictive Technology
Cell-based Assays Market by End-User: Pharma & Biotech Companies Academic Institutes CROs
This report provides individual revenue forecasts to 2028 for these national markets: US Japan Germany UK France Spain Italy China India Russia Brazil
Our study includes SWOT and STEP analysis of the cell-based assays market.
Our study discusses the selected leading companies that are the major players in the cell-based assays market: BD (Becton, Dickinson and Company) BioAgilytix Labs BioVision Cell Assay Innovations, Inc. Charles River Laboratories International CYTOO SA DiscoverX GE Healthcare InSphero Marin Biological Laboratories Molecular Devices Perkin Elmer Pharmaceutical Product Development Porsolt Promega ProQinase GmbH QGel SGS Group, Inc. Thermo Fisher Scientific (and Affymetrix acquisition)
This report also discusses technology, trends and future outlook of the cell-based assays industry
Visiongain's study is intended for anyone requiring commercial analyses for the cell-based assays market. You find data, trends and predictions.
Buy our report today Cell-Based Assays World Industry and Market 2018-2028: Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs.
To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/cell-based-assays-world-industry-and-market-2018-2028/
Abcam Accuri Cytometers, Inc. Affymetrix, Inc. Agilent Technologies Applied Biosystems Ascendance Biotechnology AstraZeneca ATCC AXAM Axiogenesis AG B'SYS GmbH BASF Bayer Becton, Dickinson and Company Becton Dickinson Asia Limited Becton Dickinson Biosciences BioAgilytix Labs BioCity Biocroi Biofungitek BioIVT Biotechnology Industry Research Assistance Council (BIRAC) BioVision, Inc. BMG LABTECH GmbH C.R. Bard Caliper Life Sciences, Inc. Cambridge Research & Instrumentation, Inc. Cell Assay Innovations (CAI) Cell Biolabs Charles River Germany GmbH & Co. KG Charles River Holdings LLC Charles River Laboratories Charles River Laboratories International, Inc. Charles River Laboratories, Inc. Charles River Nederland BV Charles River UK Limited Cisbio Bioassays Cohesive Technologies Inc. Contextual Genomics CYTOO SA Daiichi Sankyo Company Limited Danaher Corporation Department of Biotechnology (DBT) DiscoverX Dr. Reddy's Laboratories Draconis Pharma Eurofins Scientific S.E. EUROIMMUN US Inc. Food and Drug Administration (FDA) Fisher Scientific FLUOFARMA Foundation Top Institute Pharma Fulcrum Therapeutics GE Healthcare GE Healthcare AS GE Healthcare Bio-Sciences AB GE Healthcare BVBA GE Healthcare European Holdings SARL GE Healthcare Japan Corporation GE Healthcare USA Holding LLC General Electric Company GIMDx, Inc. Guangzhou Improve Medical Instruments HD Biosciences Co., Ltd. Helsinki Institute of Life Science Icagen, Inc. Idengene SA IncellDx, Inc Indian Institute of Chemical Technology (IICT) Innoprot InSphero AG IntelliCyt Interchim Invitrogen Janssen Jubilant Biosys Labcyte Inc. Lead Discovery Centre GmbH Likarda Luxcel Biosciences Ltd Marin Biologic Laboratories Mayflower Biosciences Merck KGaA Metrion Biosciences Ltd Molecular Devices, LLC NanoString Technologies, Inc. Ncardia NEOMED Institute Netherlands Cancer Institute Neuron BioServices NovaScreen Biosciences Corporation NovaWave Technologies, Inc. On Target Co., Ltd Oncotest Pelago Bioscience Perkin Elmer Inc. Phadia GmbH Pharmaceutical Product Development (PPD) Pharmaceutical Product Development, LLC. Phenomics Discovery Initiative (PDi) Pluriomics B.V. Porsolt Porsolt and Fluofarma acquisition Premas Lifescience Promega Corporation ProQinase GmbH QGel SA. Riken Genesis Russian Federation Sanofi Science Exchange SGS Australia SGS Belgium NV SGS Central America S.A. SGS Group SGS North America Inc. Skolkovo Foundation StemTek therapeutics Sygnature Discovery Syncom Sysmex Corporation Systems and Reagents Inc. Takeda Pharmaceutical Company Limited Tecan Group Ltd. The Structural Genomics Consortium Thermo Electron A/S Thermo Fisher Scientific (and Affymetrix acquisition) Thermo Fisher Scientific Operating Company LLC Thermo Fisher Scientific Senior Financing LLC Thermo Scientific Tufts Center for the Study of Drug Development UCB Unity Lab Services Valneva SE VitoTag Biosciences Xenogen Corporation ZF BioLabs ZF Biotox List of Organisations mentioned in the report All India Institute of Medical Sciences (AIIMS) American Society of Cell Biology (ASCB) AMR Centre (AMRC) Association of Research-Based Pharmaceutical Companies Biotechnology Industry Research Assistance Council (BIRAC) Department of Biotechnology (DBT) Foundation Top Institute Pharma Helsinki Institute of Life Science Imperial College London Indian Institute of Chemical Technology (IICT) Innovative Medicines Initiative (IMI) nstitute for Chemical Sciences in Rennes Institute for In Vitro Sciences, Inc. (IIVS) Institute for Molecular Medicine Finland (FIMM) Karolinska Institutet Medical Research Council (MRC) Centre for Regenerative Medicine (CRM) Memorial Sloan Kettering Cancer Center (MSK) National Health Service (NHS) National Phenotypic Screening Centre (NPSC) NEOMED Institute Netherlands Cancer Institute Oxford University Pharmaceutical Research and Manufacturers of America (PhRMA) Phenomics Discovery Initiative (PDi) Russian Federation Science Exchange Skolkovo Foundation Tufts Center for the Study of Drug Development Unity Lab Services University of Dundee University of Edinburgh University of Helsinki University of Oxford World Health Organization (WHO)
To see a report overview please e-mail Sara Peerun on [email protected]
SOURCE Visiongain
